Megaspas Tablet
By Megaspas
Rx
10 Tablet in a Strip

Composition
Dicyclomine(10mg) + Paracetamol(325mg) + Mefenamic Acid(250mg)

Manufacturer - MDC Pharmaceuticals Pvt Ltd
MDC PHARMACUETICALS PVT. LIMITED, PLOT NO. 213, INDUSTRIAL AREA, PHASE, I CHANDIGARH-160002. (INDIA)

Expires on or after
May, 2026

liver
When using Megaspas Tablet, it is important to be cautious if you have liver disease. Patients with liver problems may require dose adjustments when taking this medication. It is recommended to consult your doctor before using Megaspas Tablet to ensure the proper dosage and usage in relation to liver conditions.

kidney
Megaspas Tablet requires caution in kidney disease. Dosage adjustment may be necessary, consult your doctor. Avoid in severe kidney disease.

alcohol
It is not recommended to drink alcohol while taking Megaspas Tablet.

driving
Megaspas Tablet could reduce alertness, impair vision, cause drowsiness, and dizziness. Avoid driving if such symptoms arise.

pregnancy
Megaspas Tablet is considered unsafe during pregnancy. Animal studies have shown potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before use.

breastfeeding
During breastfeeding, it is advised to avoid using Megaspas Tablet as it may not be safe. Limited human studies indicate potential harm to the baby as the drug may pass into breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹50
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024